Melio
PrivateLast Round
Grant
Jan 14, 2025
Total Funding Raised
$10.7M
Company Overview
Melio is a biotechnology company developing a rapid, culture-free bloodborne pathogen testing platform that integrates proprietary assays, microfluidics, and machine learning to identify infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Medical AI, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Melio Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Melio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 14, 2025 | ||||
| Seed | Jun 30, 2024 |
Melio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lexi Ventures | Seed |
| MIT Alumni Angels of Northern California | Seed |
| CARB-X | Grant, Seed |
| Catalytic Impact Foundation | Seed |
| Cove Fund | Seed |
| Little Green Bamboo Capital | Seed |
| LongeVC | Seed |
Melio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Melio's valuation, stock price, and market status.